Rapport
Rapport, a J&J Neuroscience Spinout, Prepares for Summer IPO as the First Biotech of the Season
Rapport, IPO, J&J, neuroscience, biotech, summer plans, Third Rock.
Rapport Neuroscience Biotech Aims for Expansion with Initial Public Offering
Rapport, neuroscience, biotech, IPO, clinical-stage, expansion, pharmaceuticals, neurological disorders, mental health